/
CLPT
$19.43+$0.95 (+5.14%)live
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$554.2M
30M shares
52-week range
$8.27 – $30.10
51% from low
Sector
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Exchange
NASDAQ
CS
Borrow rate
0.54%
Easy to borrow
Price (6 mo)
Loading chart…
Change+$0.34
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $7.4M | $11.2M | $12.8M | $16.3M | $20.6M | $24.0M | $31.4M | $37.0M |
| Cost of revenue | $2.4M | $3.9M | $3.7M | $5.2M | $7.0M | $10.3M | $12.3M | $14.3M |
| Gross profit | $4.9M | $7.3M | $9.1M | $11.1M | $13.5M | $13.6M | $19.1M | $22.7M |
| Gross margin | 66.9% | 64.9% | 71.1% | 68.2% | 65.8% | 56.8% | 60.9% | 61.4% |
| R&D | $2.3M | $2.8M | $4.7M | $9.3M | $10.9M | $11.7M | $12.4M | $13.9M |
| Operating income | −$5.2M | −$4.6M | −$6.2M | −$13.4M | −$16.3M | −$22.4M | −$19.7M | −$24.2M |
| EBITDA | −$5.1M | −$4.3M | −$4.8M | −$12.7M | −$15.6M | −$20.6M | −$17.0M | −$20.9M |
| Net income | −$6.2M | −$5.5M | −$6.8M | −$14.4M | −$16.4M | −$22.1M | −$18.9M | −$25.5M |
| Net margin | -83.8% | -49.4% | -52.9% | -88.4% | -80.0% | -92.2% | -60.3% | -69.1% |
| EPS (diluted) | -0.56 | -0.49 | -0.43 | -0.69 | -0.68 | -0.90 | -0.70 | -0.90 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $53M | $-1.11 | $-1.16–$-1.07 | 2 |
| 2027 | $64M | $-0.94 | $-1.15–$-0.73 | 2 |
| 2028 | $77M | $-0.87 | $-0.90–$-0.84 | 1 |
| 2029 | $92M | $-0.65 | $-0.67–$-0.62 | 1 |
Forward consensus · source: Financial Modeling Prep
Peer comparison
ClearPoint Neuro, Inc. Common Stock
ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.
www.clearpointneuro.com- Employees
- 172
- IPO / List date
- May 18, 2012
- HQ
- SOLANA BEACH, CA
Held by traders on TradeandTell
No one on the platform currently holds CLPT.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2025-12-31 | 120,000 | $1.6M |
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2015-07-27 | 1-for-35reverse |
Recent trades on TradeandTell
No one on the platform has traded CLPT yet.
